User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 13:35, 22 July 2018
, 22 July 2018→CBD: + Isolated and identified in 1940
imported>Jukeboksi m (typo) |
imported>Jukeboksi (→CBD: + Isolated and identified in 1940) |
||
| Line 105: | Line 105: | ||
=== CBD === | === CBD === | ||
[[File:Cannabidiol.svg|thumb|right|200px|[[w:Cannabidiol|Cannabidiol]] has very low [[w:affinity (pharmacology)|affinity]] for the [[w:cannabinoid receptor|cannabinoid]] [[w:Cannabinoid receptor type 1|CB<sub>1</sub>]] and [[w:Cannabinoid receptor type 2|CB<sub>2</sub>]] receptors receptors but acts as an indirect [[w:receptor antagonist|antagonist]] of cannabinoid [[w:agonist|agonist]]s.]] | [[File:Cannabidiol.svg|thumb|right|200px|[[w:Cannabidiol|Cannabidiol]] has very low [[w:affinity (pharmacology)|affinity]] for the [[w:cannabinoid receptor|cannabinoid]] [[w:Cannabinoid receptor type 1|CB<sub>1</sub>]] and [[w:Cannabinoid receptor type 2|CB<sub>2</sub>]] receptors receptors but acts as an indirect [[w:receptor antagonist|antagonist]] of cannabinoid [[w:agonist|agonist]]s.]] | ||
[[w:Cannabidiol|Cannabidiol]] has the most medical applications of all phytocannabinoids. | [[w:Cannabidiol|Cannabidiol]] and it was isolated and identified from Cannabis sativa in 1940<ref name="enwiki_thc">https://en.wikipedia.org/wiki/Tetrahydrocannabinol</ref>. | ||
has the most medical applications of all phytocannabinoids. | |||
{{Q|Cannabidiol has little affinity for [[w:Cannabinoid receptor#CB1|CB<sub>1</sub>]] and [[w:Cannabinoid receptor#CB2|CB<sub>2</sub>]] receptors but acts as an indirect [[w:Receptor antagonist|antagonist]] of cannabinoid [[w:agonist|agonist]]s.<ref name="recentadvances">{{cite journal|doi=10.1002/cbdv.200790147 |title=Cannabidiol – Recent Advances |year=2007 |last1=Mechoulam |first1=Raphael |last2=Peters |first2=Maximilian |last3=Murillo-Rodriguez |first3=Eric |last4=Hanuš |first4=Lumír O. |journal=Chemistry & Biodiversity |volume=4 |issue=8 |pages=1678–92 |pmid=17712814}}</ref>|Wikipedia|[[w:Cannabinoid#Cannabidiol|Cannabidiol]]}} | {{Q|Cannabidiol has little affinity for [[w:Cannabinoid receptor#CB1|CB<sub>1</sub>]] and [[w:Cannabinoid receptor#CB2|CB<sub>2</sub>]] receptors but acts as an indirect [[w:Receptor antagonist|antagonist]] of cannabinoid [[w:agonist|agonist]]s.<ref name="recentadvances">{{cite journal|doi=10.1002/cbdv.200790147 |title=Cannabidiol – Recent Advances |year=2007 |last1=Mechoulam |first1=Raphael |last2=Peters |first2=Maximilian |last3=Murillo-Rodriguez |first3=Eric |last4=Hanuš |first4=Lumír O. |journal=Chemistry & Biodiversity |volume=4 |issue=8 |pages=1678–92 |pmid=17712814}}</ref>|Wikipedia|[[w:Cannabinoid#Cannabidiol|Cannabidiol]]}} | ||